Cardioverter Defibrillators/Cardiac Resynchronization Therapy - Medicare Advantage

Covers implantable cardioverter‑defibrillators (transvenous, subcutaneous, extravascular), cardiac resynchronization therapy (LV coronary venous leads/CRT), cardiac contractility modulation systems, external/garment‑type AEDs and related replacement components for patients with systolic heart failure and conduction delay (CRT candidates) or those at risk for life‑threatening ventricular tachyarrhythmia/sudden cardiac death. The provided excerpt contains no explicit coverage criteria or patient‑selection thresholds; several codes are new (effective 1/1/2025), some items are replacement‑only (e.g., K1030, K0607–K0609), and coverage/payability will depend on medical‑necessity documentation, coding/bundling rules and evolving evidence for emerging technologies.

"No explicit limitations, exclusions, or frequency restrictions are stated in the provided excerpt."

Sign up to see full coverage criteria, indications, and limitations.